Game Creek Capital, LP Gilead Sciences, Inc. Transaction History

Game Creek Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $1.1 Million - $1.39 Million	-17,750 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $289,360 - $336,000	4,000 Added 29.09%	17,750 $1.37 Million
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $861,162 - $1.1 Million	13,750 New	13,750 $1.03 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $364,200 - $444,000	-5,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $355,750 - $417,600	5,000	5,000 $0

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Game Creek Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Game Creek Capital, LP with notifications on news.